Novo Nordisk (NVO) is up 9.0%, or $4.34 to $52.44.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Unusually active option classes on open December 23rd
- Morning Movers: Novo Nordisk gains after Wegovy pill approved
- Video: HII sails higher as President unveils plans for ‘Trump-class’ battleships
- Novo Nordisk: Oral Wegovy Approval Restores Momentum but Competitive Pressures Justify Hold Rating
- Novo’s Wegovy pill is planned to enter U.S. self-pay channels, Reuters says